Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01930526|
Recruitment Status : Completed
First Posted : August 29, 2013
Last Update Posted : January 5, 2016
|Condition or disease||Intervention/treatment||Phase|
|Chronic Obstructive Pulmonary Disease (COPD)||Other: Pulmonary Rehabilitation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||22 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation|
|Study Start Date :||July 2011|
|Actual Primary Completion Date :||November 2012|
|Actual Study Completion Date :||October 2015|
Experimental: Pulmonary Rehabilitation
Patients will undergo the usual pulmonary rehabilitation programme but instead of two-legged cycling they will undergo single leg cycling where they cycle with one leg for 10-15mins and then the other in the same session.
Other: Pulmonary Rehabilitation
Pulmonary Rehabilitation (PR) is a short course 6-12 weeks of supervised exercise training and education for patients with COPD. This is part of their usual treatment. This study is replacing two-legged cycling with single leg training. Patients will have the usual PR outcome measures assessed but in addition will have a laboratory exercise test.
- Change in peak oxygen uptake achieved by incremental cycle ergometry [ Time Frame: Measured at the end of an average of eight weeks of pulmonary rehabilitation compared to baseline ]A full incremental cardiopulmonary exercise test will be performed on a cycle ergometer to symptom limitation with expiratory gas analysis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01930526
|West Park Healthcare Centre|
|Toronto, Ontario, Canada, M6M 2J5|
|Principal Investigator:||Roger S Goldstein, MBChB||West Park Healthcare Centre|